RxDoctor Payments Data

Charles Demario

Family Medicine · Newton Falls, OHNPI 1629070552

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Novo Nordisk at 25.9% of the total. Reporting peaked in 2021 at $524 and has fallen 66.7% since, to $175 in 2022.

$1,418in general payments, 2019–2025

Across 98 payments — averaging $14.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$367
  • AstraZeneca$294
  • GSK$149
  • Boehringer Ingelheim$141
  • Pfizer$90
  • Bayer$84
  • plus $293 from 11 others

What the payments were for

  • Food & beverage$1,418100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,418 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
RivastigmineRivastigmine Tartrate13$2,386
Mirtazapine13$152

Paid to pharmacies, not to this prescriber.

Other family medicine in Newton Falls

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →